The Peripheral Rotational Atherectomy industry trends have shown significant momentum over the past 18 months, driven by strategic partnerships and technological innovation. Companies like Infinova Medical and Medtronic have forged alliances to expand distribution networks in Asia-Pacific markets, while Boston Scientific acquired Avinger Inc. to integrate advanced image-guided atherectomy solutions. Regulatory developments, including FDA clearance for next-gen diamond-coated burrs with enhanced safety profiles, have accelerated adoption. Meanwhile, the launch of compact, single-use devices by companies such as Philips has addressed procedural efficiency demands. Enterprise trends reveal a shift toward outpatient procedures, boosting demand for cost-effective, rapid-recovery solutions. Notably, a $75M Series B funding round for startup Vascular Dynamics enabled R&D in AI-driven plaque assessment tools, signaling a pivot toward data-centric care. As reimbursement policies evolve and chronic limb-threatening ischemia prevalence rises, the sector is poised for disruptive growth through cross-industry collaboration and precision-focused technologies.